Home About us Contact
|
Home About us Contact | ||
|
|
||
Potential Promise (potential + promise)
Selected AbstractsCLINICAL STUDY: The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a reviewADDICTION BIOLOGY, Issue 3 2009Shubh M. Singh ABSTRACT The concept of endophenotypes has gained popularity in recent years. This is because of the potential that endophenotypes provide of measuring objective trait markers that are simpler to access and assess than complex behavioral disease phenotypes themselves. The simplicity, ease of measurement and the putative links to the etiology of the disease in the study of an endophenotype has the potential promise of unraveling the genetic basis of the disease in question. Of the various proposed endophenotypes, the P300 component of the event-related potential has been used in studies on alcoholism, schizophrenia and externalizing disorders. The current state of knowledge regarding the concept of endophenotypes, P300 and the validity of P300 as an endophenotype with special reference to substance use disorders is discussed in this review. The implications of the above are discussed. [source] Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial resultsINTERNATIONAL JOURNAL OF CANCER, Issue 1 2009Jennifer M. Yeh Abstract Gastric cancer is the second leading cause of cancer-related deaths worldwide. Treatment for Helicobacter pylori infection, the leading causal risk factor, can reduce disease progression, but the long-term impact on cancer incidence is uncertain. Using the best available data, we estimated the potential health benefits and economic consequences associated with H. pylori screening in a high-risk region of China. An empirically calibrated model of gastric cancer was used to project reduction in lifetime cancer risk, life-expectancy and costs associated with (i) single lifetime screening (age 20, 30 or 40); (ii) single lifetime screening followed by rescreening individuals with negative results and (iii) universal treatment for H. pylori (age 20, 30 or 40). Data were from the published literature and national and international databases. Screening and treatment for H. pylori at age 20 reduced the mean lifetime cancer risk by 14.5% (men) to 26.6% (women) and cost less than $1,500 per year of life saved (YLS) compared to no screening. Rescreening individuals with negative results and targeting older ages was less cost-effective. Universal treatment prevented an additional 1.5% to 2.3% of risk reduction, but incremental cost-effectiveness ratios exceeded $2,500 per YLS. Screening young adults for H. pylori could prevent one in every 4 to 6 cases of gastric cancer in China and would be considered cost-effective using the GDP per capita threshold. These results illustrate the potential promise of a gastric cancer screening program and provide rationale for urgent clinical studies to move the prevention agenda forward. © 2008 Wiley-Liss, Inc. [source] Current Status of Metals as Therapeutic Targets in Alzheimer's DiseaseJOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 8 2003Anne E. Finefrock MA There is accumulating evidence that interactions between ,-amyloid and copper, iron, and zinc are associated with the pathophysiology of Alzheimer's disease (AD). A significant dyshomeostasis of copper, iron, and zinc has been detected, and the mismanagement of these metals induces ,-amyloid precipitation and neurotoxicity. Chelating agents offer a potential therapeutic solution to the neurotoxicity induced by copper and iron dyshomeostasis. Currently, the copper and zinc chelating agent clioquinol represents a potential therapeutic route that may not only inhibit ,-amyloid neurotoxicity, but may also reverse the accumulation of neocortical ,-amyloid. A Phase II double-blind clinical trial of clioquinol with B12 supplementation will be published soon, and the results are promising. This article summarizes the role of transition metals in amyloidgenesis and reviews the potential promise of chelation therapy as a treatment for AD. [source] Endothelial cell growth on silicon modified hydrogenated amorphous carbon thin filmsJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 1 2008A. A. Ogwu Abstract The biological response of human microvascular endothelial cells (HMEC-1) seeded on Si-DLC films and on control surfaces was evaluated in terms of initial cell enhancement, growth, and cytotoxicity. The microstructure of the films was characterised by Raman spectroscopy and X-ray photoelectron spectroscopy. The effect of changes in microstructure, surface energy, surface electronic state, and electronic conduction, on the biological response of the films to endothelial cells was investigated. Endothelial cell adhesion and growth was found to be affected by changes in the microstructure of the films induced by silicon doping and thermal annealing. We observed a significant statistical difference in endothelial cell count between the as-deposited DLC and Si-DLC films using the one sample t -test at a p -value of 0.05. We also found a statistically significant difference between the adhesion of HMEC films on DLC and Si-DLC films at various annealing temperatures using the one-way ANOVA F statistic test at p < 0.05 and the post-hoc Tukey test. One sample t -test at p < 0.05 of MTT-assay results showed the endothelial cells to be viable when seeded on DLC/Si-DLC films. We suspect that the increased adhesion of endothelial cells induced by increasing the amount of silicon in the Si-DLC films is associated with the development of a suitable surface energy due to silicon addition, which neither favored cell denaturing nor preferential water spreading before cellular attachment on the film surface. The presence of an external positively charged dipole on the Si-DLC films confirmed by our Kelvin probe measurements is also expected to enhance the adhesion of endothelial cells that are well known to carry a negative charge. The Si-DLC films investigated hold potential promise as coatings for haemocompatible artificial implants. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] Aerobic degradation by white-rot fungi of trichloroethylene (TCE) and mixtures of TCE and perchloroethylene (PCE)JOURNAL OF CHEMICAL TECHNOLOGY & BIOTECHNOLOGY, Issue 9 2008Ernest Marco-Urrea Abstract BACKGROUND: Trichloroethylene (TCE) and perchloroethylene (PCE) are considered among the most important groundwater pollutants around the world. These compounds are usually found together in polluted environments but little is known about the ability of microorganisms to simultaneously degrade TCE and PCE. RESULTS: Data showed that several species of white-rot fungi, including Trametes versicolor, Ganoderma lucidum, and Irpex lacteus, degrade substantial levels of TCE in pure culture. T. versicolor was chosen for further study since it degraded higher levels of TCE than the other organisms. Initial glucose concentration and reoxygenation of samples increased the amount of TCE dechlorination, but no significant difference in percentage TCE degradation was observed. T. versicolor was able to degrade 34.1 and 47.7% of PCE and TCE added as mixtures (containing 5 and 10 mg L,1, respectively). CONCLUSIONS: The degradation ability of TCE was extended to other species of white-rot fungi. Percentage degradation as well as chloride release from mixtures of TCE and PCE showed that T. versicolor degrades mixtures of TCE and PCE almost as well as its ability to degrade individually added TCE or PCE. The results suggest the potential promise of T. versicolor for bioremediation of TCE and PCE in the environment. Copyright © 2008 Society of Chemical Industry [source] | ||||||||||